
Opinion|Videos|April 1, 2024
Paradigm Shift In Parkinson’s Disease Diagnosis
Author(s)Stuart H. Isaacson, MD, FAAN, Rajesh Pahwa, MD
The neurology experts discuss the importance of early and accurate diagnosis of Parkinson’s disease, the role of alpha-synuclein in the diagnosis of synucleinopathies and approaches to implementing screening protocols in clinical practice.
Advertisement
Episodes in this series
0:50 Diagnosis of Parkinson’s disease
3:20 Preclinical start of Parkinson’s disease
5:00 Alpha-synuclein in Parkinson’s disease
6:50 Biomarkers in Parkinson’s disease
12:00 Syn-One test for Parkinson’s disease
21:15 Advanced diagnostics in Parkinson’s disease
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Exploring the Role of Aerobic Exercise in Promoting Remyelination in Multiple Sclerosis: Lindsey Wooliscroft, MD, MS
2
Bilateral MR-Guided Focused Ultrasound Shows Benefit for Managing Parkinson Motor Complications in Phase 3 Trial
3
NLRP3 Inhibitor VTX3232 Well Tolerated, Improves Parkinson Symptoms in Phase 2a Trial
4
Ruptured vs Unruptured Aneurysms: Practical Decision Making with Guilherme Dabus, MD
5